Ivivi Looks To Ease Post-Surgery Pain, Turn Profit With Help From Allergan
This article was originally published in The Gray Sheet
Executive Summary
Electromagnetic pain control device maker Ivivi Technologies is looking to leverage a new marketing partnership strategy along with new data and clinical guidelines to help lift its business into profitability
You may also be interested in...
People In Brief
Coapt Systems: Silicon Valley aesthetics firm appoints Laureen DeBueno as president and CEO Aug. 1. DeBueno has more than 25 years management experience in the medical device and technology markets, most recently as chief financial officer of Thermage. Coapt makes bioabsorbable implants for the fixation of soft tissue in the plastic, reconstructive and sports medicine markets
People In Brief
Coapt Systems: Silicon Valley aesthetics firm appoints Laureen DeBueno as president and CEO Aug. 1. DeBueno has more than 25 years management experience in the medical device and technology markets, most recently as chief financial officer of Thermage. Coapt makes bioabsorbable implants for the fixation of soft tissue in the plastic, reconstructive and sports medicine markets
Financings In Brief
Home Diagnostics, Inc. goes public: Blood glucose monitor firm goes public Sept. 20 via a $79 mil. offering of about 6.6 mil. common stock shares at $12 each. The Fort Lauderdale, Fla., firm will use the proceeds to buy manufacturing equipment, repay debt and redeem preferred stock. R&D projects include low-cost biosensors, on-strip coding technology and wireless connectivity enhancements. Current offerings, based on both photometric and biosensor technology, include the firm's SideKick disposable blood glucose testing system and the Prestige IQ, TrueTrack Smart and TrackEase Smart advanced systems. HDI, which generated 2005 sales of $100 mil. (up 18% for the year) and is profitable, competes with larger firms including Johnson & Johnson, Roche, Abbott, Bayer and BD, primarily by offering low-cost systems using comparable technology. The company trades under the Nasdaq symbol "HDIX"...